Natalia A. Demidova

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

CRISPR-Cas genome editing system in the diagnosis and therapy of infection caused by herpes simplex virus type 1 (Orthoherpesviridae: Alphaherpesviridae: Simplexvirus: Simplexvirus humanalpha1).

CRISPR-Cas genome editing system in the diagnosis and therapy of infection caused by herpes simplex virus type 1 (Orthoherpesviridae: Alphaherpesviridae: Simplexvirus: Simplexvirus humanalpha1).

Journal: Voprosy virusologii

Published: March 31, 2025

Dimeric Bisbenzimidazole DB2A(7) Protects Mice From Lethal Genital Herpes and Herpetic Skin Lesions.

Dimeric Bisbenzimidazole DB2A(7) Protects Mice From Lethal Genital Herpes and Herpetic Skin Lesions.

Journal: Journal of medical virology

Published: February 06, 2025

Control of HSV-1 Infection: Directions for the Development of CRISPR/Cas-Based Therapeutics and Diagnostics.

Control of HSV-1 Infection: Directions for the Development of CRISPR/Cas-Based Therapeutics and Diagnostics.

Journal: International journal of molecular sciences

Published: October 05, 2024

Detection rates and high concentration of herpesvirus (Orthoherpesviridae) DNA in autopsy materials from patients with COVID-19 fatal outcome

Detection rates and high concentration of herpesvirus (Orthoherpesviridae) DNA in autopsy materials from patients with COVID-19 fatal outcome

Journal: Voprosy virusologii

Published: January 15, 2024

The adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae: Hepacivirus)proteins and is synergistically enhanced in combination with pyrogenalum, a TLR4 agonist.

The adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae: Hepacivirus)proteins and is synergistically enhanced in combination with pyrogenalum, a TLR4 agonist.

Journal: Voprosy virusologii

Published: June 28, 2023

Adjuvant effect of dispersed fullerene C60 on the immune response to constructs harboring amino acid and nucleotide sequences of hepatitis C virus nonstructural NS5B protein

Adjuvant effect of dispersed fullerene C60 on the immune response to constructs harboring amino acid and nucleotide sequences of hepatitis C virus nonstructural NS5B protein

Journal: Voprosy virusologii

Published: December 26, 2022

Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.

Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.

Journal: International journal of molecular sciences

Published: October 30, 2022

Preventive Vaccination with Mesenchymal Stem Cells Protects Mice from Lethal Infection Caused by Herpes Simplex Virus 1

Preventive Vaccination with Mesenchymal Stem Cells Protects Mice from Lethal Infection Caused by Herpes Simplex Virus 1

Journal: Molekuliarnaia biologiia

Published: August 13, 2020

Preventive Vaccination with Mesenchymal Stem Cells Protects Mice from Lethal Infection Caused by Herpes Simplex Virus 1.

Preventive Vaccination with Mesenchymal Stem Cells Protects Mice from Lethal Infection Caused by Herpes Simplex Virus 1.

Journal: Molecular biology

Published: August 13, 2020

The place of riociguat in the treatment of patients with pulmonary arterial hypertension associated with systemic connective tissue diseases

The place of riociguat in the treatment of patients with pulmonary arterial hypertension associated with systemic connective tissue diseases

Journal: Kardiologiia

Published: May 18, 2020

Development and properties of neutralizing monoclonal antibodies for fusion protein of respiratory syncytial virus.

Development and properties of neutralizing monoclonal antibodies for fusion protein of respiratory syncytial virus.

Journal: Voprosy virusologii

Published: October 20, 2018

A Plasmid-Expressed CRISPR/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture

A Plasmid-Expressed CRISPR/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture

Journal: Molekuliarnaia biologiia

Published: August 28, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026